Join our Newsletter
Browse by Category
-
Most Read This Week
- Vical Incorporated announces results of herpes vaccine trial
- NIH studying newly emerging Staphylococcus aureus strain
- University of Cincinnati researchers develop oral breast cancer vaccine
- CDC issues update on fungal meningitis outbreak
- Japan deals with rubella outbreak
- Swine-origin flu variant cases continue in U.S.
- Scientist map critical portion of anti-influenza antibody
- Boy dies from superbug infection at NIH hospital
- Progress made on new TB drug
Tags
Africa AIDS anthrax Avian flu Canada Cancer CDC Centers for Disease Control chicken pox China cholera Dengue fever Detection technology Ebola H1N1 H5N1 Hepatitis Hepatitis B HIV HPV Human papillomavirus immunization India Infectious disease Influenza Malaria Maryland Measles Medical Countermeasures meningitis MRSA Mumps News Pertussis pneumonia polio Preparedness research rotavirus Tuberculosis vaccine development West Nile virus whooping cough World Health Organization Yellow Fever
Tag Archives: Human papillomavirus
Two doses of HPV vaccine as good as three, study shows
_EM.jpg)
According to data from the National Cancer Institute’s Costa Rica Vaccine Trial, two does of the human papillomavirus vaccine may offer as much protection against cervical cancer as the three dose regimen currently being used. Read More »
Study shows HPV vaccine can be delayed with minimal loss of effectiveness
A recent study conducted by Kathleen M. Neuzil has found that delaying doses of the vaccine against human papilloma virus until months later than recommended does not make the vaccine less safe or effective. Read More »
Only one-third of U.S. women receive full HPV vaccine
A recent study showed that only around one-third of eligible young U.S. women complete the full course of the human papillomavirus vaccine. Read More »
Experts debate HPV vaccine for males
Federal vaccine advisors began deciding on October 28 whether or not two vaccines that protect against sexually transmitted diseases that can cause genital warts and cancers should be used widely in boys and young men. Read More »
Grant awarded for trial of new HPV vaccine
Researchers with the University of Arkansas for Medical Sciences have been awarded a $3.3 million grant for clinical trials of a new HPV vaccine. Read More »
Cervarix license amended for additional HPV strains
GlaxoSmithKline Read More »
HPV vaccine may protect against genital warts
The results of a four-year study released on July 20 by the British Medical Journal show that vaccination against certain types of human papillomavirus gives protection against genital warts and pre-cancerous growths of the cervix. Read More »
QIAGEN HPV test improves cervical cancer control
Researchers with QIAGEN said a recent study has shown that Latin American women who used its human papillomavirus test showed improved cervical cancer control when compared to regular cytology testing. Read More »